Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Danish Regenerative Engineering Alliance for Medicine, Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Gigascience. 2018 Mar 1;7(3):1-19. doi: 10.1093/gigascience/giy011.
Fusion of DNA methyltransferase domains to the nuclease-deficient clustered regularly interspaced short palindromic repeat (CRISPR) associated protein 9 (dCas9) has been used for epigenome editing, but the specificities of these dCas9 methyltransferases have not been fully investigated.
We generated CRISPR-guided DNA methyltransferases by fusing the catalytic domain of DNMT3A or DNMT3B to the C terminus of the dCas9 protein from Streptococcus pyogenes and validated its on-target and global off-target characteristics. Using targeted quantitative bisulfite pyrosequencing, we prove that dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B can efficiently methylate the CpG dinucleotides flanking its target sites at different genomic loci (uPA and TGFBR3) in human embryonic kidney cells (HEK293T). Furthermore, we conducted whole genome bisulfite sequencing (WGBS) to address the specificity of our dCas9 methyltransferases. WGBS revealed that although dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B did not cause global methylation changes, a substantial number (more than 1000) of the off-target differentially methylated regions (DMRs) were identified. The off-target DMRs, which were hypermethylated in cells expressing dCas9 methyltransferase and guide RNAs, were predominantly found in promoter regions, 5΄ untranslated regions, CpG islands, and DNase I hypersensitivity sites, whereas unexpected hypomethylated off-target DMRs were significantly enriched in repeated sequences. Through chromatin immunoprecipitation with massive parallel DNA sequencing analysis, we further revealed that these off-target DMRs were weakly correlated with dCas9 off-target binding sites. Using quantitative polymerase chain reaction, RNA sequencing, and fluorescence reporter cells, we also found that dCas9-BFP-DNMT3A and dCas9-BFP-DNMT3B can mediate transient inhibition of gene expression, which might be caused by dCas9-mediated de novo DNA methylation as well as interference with transcription.
Our results prove that dCas9 methyltransferases cause efficient RNA-guided methylation of specific endogenous CpGs. However, there is significant off-target methylation indicating that further improvements of the specificity of CRISPR-dCas9 based DNA methylation modifiers are required.
将 DNA 甲基转移酶结构域融合到无核酸酶活性的成簇规则间隔短回文重复序列(CRISPR)相关蛋白 9(dCas9)上,已被用于表观基因组编辑,但这些 dCas9 甲基转移酶的特异性尚未得到充分研究。
我们通过将 DNMT3A 或 DNMT3B 的催化结构域与酿脓链球菌的 dCas9 蛋白的 C 末端融合,生成了 CRISPR 引导的 DNA 甲基转移酶,并验证了其在靶标和全基因组脱靶特性。通过靶向定量亚硫酸氢盐焦磷酸测序,我们证明 dCas9-BFP-DNMT3A 和 dCas9-BFP-DNMT3B 可以有效地甲基化人胚肾细胞(HEK293T)中不同基因组位点(uPA 和 TGFBR3)的靶标位点侧翼的 CpG 二核苷酸。此外,我们进行了全基因组亚硫酸氢盐测序(WGBS)以解决我们的 dCas9 甲基转移酶的特异性问题。WGBS 表明,尽管 dCas9-BFP-DNMT3A 和 dCas9-BFP-DNMT3B 不会导致全局甲基化变化,但鉴定出了大量(超过 1000 个)的脱靶差异甲基化区域(DMR)。在表达 dCas9 甲基转移酶和向导 RNA 的细胞中,脱靶 DMR 呈超甲基化状态,主要位于启动子区域、5'非翻译区、CpG 岛和 DNase I 超敏位点,而意想不到的脱靶低甲基化 DMR 则明显富集于重复序列。通过大规模平行 DNA 测序分析的染色质免疫沉淀实验,我们进一步表明这些脱靶 DMR 与 dCas9 脱靶结合位点弱相关。通过定量聚合酶链反应、RNA 测序和荧光报告细胞,我们还发现 dCas9-BFP-DNMT3A 和 dCas9-BFP-DNMT3B 可以介导基因表达的瞬时抑制,这可能是由 dCas9 介导的新 DNA 甲基化以及对转录的干扰引起的。
我们的结果证明 dCas9 甲基转移酶可以有效地引导特异性内源性 CpG 的 RNA 指导甲基化。然而,存在显著的脱靶甲基化,这表明需要进一步提高基于 CRISPR-dCas9 的 DNA 甲基化修饰物的特异性。